Gut hormone leads to weight loss in overweight or obese patients
Giving overweight or obese patients a gut hormone that suppresses appetite leads to clinically beneficial weight loss as well as reduced blood pressure and cholesterol levels, finds a study published in the British Medical Journal today.
Glucagon-like peptide-1 (GLP-1) is a hormone that is secreted from the intestine when we eat. GLP-1 based therapy was recently introduced as a new treatment for patients with type 2 diabetes because of its ability to regulate blood sugar levels.
But it also suppresses food intake and appetite, making it an interesting approach in the treatment of obesity.
So researchers at the University of Copenhagen set out to determine the effect of glucagon-like peptide-1 receptor (GLP-1R) agonists on weight loss. They also looked at their effect on blood pressure, cholesterol and liver enzyme levels, and blood sugar (glycaemic) control.
They analysed the results of 25 randomised controlled trials involving over 6,000 patients. Differences in study design and quality were taken into account to minimise bias.
They found that patients who received clinically relevant doses of GLP-1R agonists for at least 20 weeks achieved a greater weight loss compared with the control groups.
The benefit was seen for patients with and without type 2 diabetes, but may be more pronounced in patients without diabetes.
GLP-1R agonists also had beneficial effects on blood pressure, cholesterol and improved glycaemic control in patients with type 2 diabetes. There was no statistically significant effect on liver enzymes.
Common side effects included nausea, vomiting and diarrhoea, but did not seem to affect the number of patients dropping out of the trials, suggesting that overall patient satisfaction with the treatment is relatively high.
The authors say that their analysis "provides convincing evidence that GLP-1R agonists, when given to obese patients with or without diabetes, result in clinically relevant beneficial effects on body weight. Additional beneficial effects on blood pressure and total cholesterol might also be achieved."
They believe that the intervention "should be considered in patients with diabetes who are obese or overweight" and call for further studies "to elucidate the effects of GLP-1R agonists in the treatment of obese patients without diabetes."
While these results highlight the weight-reducing benefits of GLP-1 agonists, they should not alter current practice, says Professor Raj Padwal from the University of Alberta in an accompanying editorial. He argues that "modification of diet and lifestyle remains the cornerstone of the treatment of type 2 diabetes."
He also points out that the safety of GLP-1 agonists is still unknown and says "continued and close surveillance of these new agents using all available data sources is warranted."
Provided by British Medical Journal
- Research reveals hormone action that could lead to treatments for type 2 diabetes Sep 30, 2011 | not rated yet | 0
- Improving psoriasis with GLP-1 analogue therapy Dec 13, 2011 | not rated yet | 0
- A new molecule to combat diabetes and obesity Sep 01, 2009 | not rated yet | 0
- Welsh medics to examine how surgery can cure diabetes May 31, 2007 | not rated yet | 0
- Potential mechanisms for future anti-obesity drugs identified Mar 03, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
How many joules expended for a push up?
3 hours ago Just wondering if any of you can do the calculation that well approximates the amount of joules expended by a push up.
force to keep the folding doors
3 hours ago Hello, I would like to ask you to calculate the force F, which needed to keep the folding doors in this position. I would like to know what is the...
Confusion regarding direction of kinetic friction on inclined plane.
4 hours ago *please help! * The formula for kinetic friction acting on a sliding body is μkN When the body is sliding with constant velocity down an...
10 hours ago Alright, so in Pathfinder (like Dungeons and Dragons) there's a spell that allows you to lift/move stuff within 25 ft with 5 pounds of force. A...
12 hours ago So energy can only be converted... So when you squeeze the bulb on a blood pressure cuff, you are applying kinetic energy. Then the cuff fills with...
How does momentum, inertia and drag affect the motion of an object?
14 hours ago How does momentum and inertia affect changes in speed, when considering acceleration from thrust, or from decelleration from drag? Say, for a...
- More from Physics Forums - Classical Physics
More news stories
(Medical Xpress)—Research by the University of Leeds has shown that very young children appear to reject story book characters who are overweight, but not those who are disabled.
Overweight and Obesity May 16, 2013 | 3 / 5 (1) | 2
(HealthDay)—Weight gain in men and women is predicted by two different genetic variations—so-called polymorphisms, according to a new study from the Netherlands.
Overweight and Obesity May 15, 2013 | 5 / 5 (1) | 0 |
(HealthDay)—Drinking 500 ml of purified water is not associated with increases in resting energy expenditure (REE), according to a study presented at the annual meeting of the European Congress on Obesity, ...
Overweight and Obesity May 14, 2013 | 2 / 5 (2) | 1
(HealthDay)—Reviews that are funded by industry tend to find the evidence weak for a causal link between sugar-sweetened beverages (SSBs) and the increasing prevalence of obesity, while other reviews consider ...
Overweight and Obesity May 14, 2013 | not rated yet | 0
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
4 minutes ago | not rated yet | 0
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
24 minutes ago | not rated yet | 0
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
2 hours ago | not rated yet | 0 |
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
2 hours ago | 5 / 5 (1) | 0
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
10 hours ago | 5 / 5 (1) | 0
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
11 hours ago | 5 / 5 (1) | 0 |